IRONWOOD PHARMACEUTICALS, INC.
IRWD · NASDAQ
Ironwood Pharmaceuticals is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. The company discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).
Market Data
Price
$3.70
+0.05 (+1.37%)
Market Cap$599M
P/E Ratio24.95
EPS$—
52W High$5.78
52W Low$0.53
Beta0.18
Data from Finnhub · Updated Mar 11, 2026